{"nctId":"NCT00418262","briefTitle":"Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in Children With FASD and ADD/ADHD","startDateStruct":{"date":"2005-08"},"conditions":["Fetal Alcohol Syndrome","Attention Deficit Hyperactivity Disorder (ADHD)"],"count":27,"armGroups":[{"label":"Atomoxetine HCL (Strattera)","type":"EXPERIMENTAL","interventionNames":["Drug: Atomoxetine"]}],"interventions":[{"name":"Atomoxetine","otherNames":["Brand Name: Strattera, Serial Number: 76306506, ACT"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patient must have been between the ages of 4 and 11 years at the time of entry into the double blind study.\n* Patients must meet diagnostic criteria for FASD.\n* Patient must, at entry into doubleblind study, have met DSM-IV criteria for ADHD, any subtype. And must have an ADHDRS-IV score of \\> or + 90% for age and gender on either subtest or total score for children above 5 years of age.\n* Patients will continue atomoxetine/placebo until entry nto this study.\n* History and physical exam must reveal no clinically significant abnormalities that would preclude safe participation in the study.\n* Patients must be able to swallow capsules.\n* Patients must be of a sufficient mental age (3 yrs) to participate in the study.\n* Patients and parents must be able to communicate effectively with the investigator and coordinator and be judged reliable to keep appointments and participate in data collection.\n* Teacher must agree to cooperate with the study.\n\nExclusion Criteria:\n\n* Have received an investigational medication other than atomoxetine in the previous 30 days.\n* Have significant current medical conditions that could be exacerbated or compromised by atomoxetine.\n* Have used MAOIs within one month prior to visit 1.\n* Patients with hypertension.\n* Patients with a previous diagnosis of bipolar disorder, psychosis, or autism spectrum disorder.\n* Patients taking anticonvulsants for seizure control.\n* Patients taking another psychotropic medication or health food supplements purported to have central nervous system activity within 5 half-lives of visit 1.\n* Patients with Tourette Disorder or any other neurological condition that would interfere with their ability to receive treatment or comply with monitoring.\n* Pubertal girls.","healthyVolunteers":false,"sex":"ALL","minimumAge":"4 Years","maximumAge":"11 Years","stdAges":["CHILD"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Pittsburg Side-Effects Scale: Motor Tics","description":"Motor Tics\n\nParent rating of none (0), mild (1) , moderate (2) or severe (3) for each manifestation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.15","spread":"0.54"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.20","spread":"0.50"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.31","spread":"0.60"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.27","spread":"0.47"}]}]}]},{"type":"PRIMARY","title":"Pittsburg Side-Effects Scale-Buccal, Lingual Movements","description":"Buccal, Lingual Movements\n\nParent rating of none (0), mild (1), moderate (2) or severe (3) for each manifestation.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":".12","spread":".33"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.2","spread":"0.50"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.44","spread":"0.73"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.27","spread":"0.47"}]}]}]},{"type":"PRIMARY","title":"Pittsburg Side-Effects Scale: Movements, Picking/Chewing Skin or Fingers","description":"Movements, Picking/Chewing Skin or Fingers\n\nParent rating of none (0), mild (1) , moderate (2) or severe (3) for each manifestation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.42","spread":"0.70"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.40","spread":"0.58"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.62","spread":"0.89"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.64","spread":"1.03"}]}]}]},{"type":"PRIMARY","title":"Pittsburg Side-Effects Scale: Worried/Anxious","description":"Worried/Anxious\n\nParent rating of none (0), mild (1) , moderate (2) or severe (3) for each manifestation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.27","spread":"0.45"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.24","spread":"0.60"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.56","spread":"0.63"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.45","spread":"0.69"}]}]}]},{"type":"PRIMARY","title":"Pittsburg Side-Effects Scale: Dull/Tired/Listless","description":"Dull/Tired/Listless\n\nParent rating of none (0), mild (1) , moderate (2) or severe (3) for each manifestation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.31","spread":"0.62"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.36","spread":"0.57"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.38","spread":"0.62"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.36","spread":"0.50"}]}]}]},{"type":"PRIMARY","title":"Pittsburg Side-Effects Scale: Headaches","description":"Headaches\n\nParent rating of none (0), mild (1) , moderate (2) or severe (3) for each manifestation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.23","spread":"0.51"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.40","spread":"0.82"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.31","spread":"0.60"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.18","spread":"0.40"}]}]}]},{"type":"PRIMARY","title":"Pittsburg Side-Effects Scale: Stomachaches","description":"Stomachaches\n\nParent rating of none (0), mild (1) , moderate (2) or severe (3) for each manifestation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.23","spread":"0.51"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.36","spread":"0.49"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.25","spread":"0.58"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.45","spread":"0.82"}]}]}]},{"type":"PRIMARY","title":"Pittsburg Side-Effects Scale: Crabby/Irritable","description":"Crabby/Irritable\n\nParent rating of none (0), mild (1) , moderate (2) or severe (3) for each manifestation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.85","spread":"0.88"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.68","spread":"0.85"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.06","spread":"0.85"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.73","spread":"0.65"}]}]}]},{"type":"PRIMARY","title":"Pittsburg Side-Effects Scale: Tearful/Sad/Depressed","description":"Tearful/Sad/Depressed\n\nParent rating of none (0), mild (1) , moderate (2) or severe (3) for each manifestation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.19","spread":"0.40"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.24","spread":"0.52"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.50","spread":"0.63"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.27","spread":"0.47"}]}]}]},{"type":"PRIMARY","title":"Pittsburg Side-Effects Scale: Socially Withdrawn","description":"Socially Withdrawn\n\nParent rating of none (0), mild (1) , moderate (2) or severe (3) for each manifestation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.12","spread":"0.43"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.16","spread":"0.47"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.25","spread":"0.58"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.09","spread":"0.30"}]}]}]},{"type":"PRIMARY","title":"Pittsburg Side-Effects Scale: Hallucinations","description":"Hallucinations\n\nParent rating of none (0), mild (1) , moderate (2) or severe (3) for each manifestation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.04","spread":"0.20"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.00","spread":"0.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.12","spread":"0.50"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.00","spread":"0.00"}]}]}]},{"type":"PRIMARY","title":"Pittsburg Side-Effects Scale: Loss of Appetite","description":"Loss of Appetite\n\nParent rating of none (0), mild (1) , moderate (2) or severe (3) for each manifestation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.46","spread":".65"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.56","spread":"0.65"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.38","spread":"0.50"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.45","spread":"0.52"}]}]}]},{"type":"PRIMARY","title":"Pittsburg Side-Effects Scale: Trouble Sleeping","description":"Trouble Sleeping Parent rating of none (0), mild (1) , moderate (2) or severe (3) for each manifestation.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.35","spread":"0.57"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.64","spread":"0.70"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.53","spread":"0.74"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.40","spread":"0.52"}]}]}]},{"type":"SECONDARY","title":"Determine if Changes in Behavior Seen With Short-term (Eight Weeks) Treatment of Children Are Maintained Over a Twelve Month Period.","description":"Parent rate the frequency of 18 of their child's behaviors from not at all (0), just a little (1) , pretty much (2) to very much (3) for each behavior. The Item scores were summed to arrive at a total score which ranged from 0 to 54. The higher the score, the worse the behavior.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"37.35","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"27.87","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"31.88","spread":null}]}]}]},{"type":"SECONDARY","title":"Compare Growth While on Atomoxetine With Growth Before Entry Into Study.","description":"Height measured in centimeters at the time of each visit as part of the vital signs.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"121.67","spread":"9.84"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"123.27","spread":"4.01"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"132.13","spread":"8.77"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":26},"commonTop":["Cough","Vomiting","Headache","Stomachache","Sleepy or Sleep Trouble"]}}}